公开(公告)号：HK1078566A1

公开(公告)日：2006-03-17

申请号：HK05110489

申请日：2005-11-21

Applicant: SERVIER LAB

Inventor： DASSONVILLE ALEXANDRA ,  BRETECHE ANNE ,  DUFLOS MURIEL ,  BAUT GUILLAUME LE ,  PFEIFFER BRUNO ,  RENARD PIERRE ,  LEVENS NIGEL ,  HUSSON-ROBERT BERNADETTE

IPC: C07C20060101 ,  A61K20060101 ,  A61K31/122 ,  A61K31/222 ,  A61K31/4402 ,  A61P20060101 ,  A61P3/10 ,  C07C45/00 ,  C07C45/28 ,  C07C46/00 ,  C07C46/10 ,  C07C50/28 ,  C07C50/30 ,  C07D20060101 ,  C07D213/50

Abstract: Compound of formula (I): wherein: R 1 and R 2 , which may be identical or different, each represents hydrogen, acyl or alkyl, Ar represents aryl or heteroaryl, A represents a group selected from: R 4 represents hydrogen or alkyl, R 5 represents hydrogen, alkyl, aryl or heteroaryl, R 3 represents aryl, heteroaryl, dicyclopropylmethyl or benzhydryl, or A-R 3 represents an optionally substituted naphthyl group, with the exclusion of 2,5-dihydroxy-3-(4-methoxyphenyl)-6-(2-phenylethenyl)-1,4-benzoquinone, 2,5-dihydroxy-3-(4-methoxyphenyl)-6-(2-naphthyl)-1,4-benzoquinone and 2,5-dihydroxy-3-(2-naphthyl)-6-phenyl-1,4-benzoquinone. Medicinal products containing the same which are useful in the treatment of diseases associated with a deregulation of glycaemia.

公开(公告)号：MA27103A1

公开(公告)日：2004-12-20

申请号：MA27795

申请日：2004-07-21

Applicant: SERVIER LAB

Inventor： DASSONVILLE ALEXANDRA ,  BRETECHE ANNE ,  DUFLOS MURIEL ,  LE BAUT GUILLAUME ,  PFEIFFER BRUNO ,  RENARD PIERRE ,  LEVENS NIGEL ,  HUSSON-ROBERT BERNADETTE

IPC: A61K31/122 ,  A61K31/222 ,  A61K31/4402 ,  A61P3/10 ,  C07C45/00 ,  C07C45/28 ,  C07C46/00 ,  C07C46/10 ,  C07C50/28 ,  C07C50/30 ,  C07D213/50

Abstract: NOUVEAUX DERIVES DE 3-ARYL-2,5-DIHYDROXY-1,4-BENZOQUINONES, LEUR PROCEDE DE PREPARATION ET LES COMPOSITIONS PHARMACEUTIQUES QUI LES CONTIENNENT Composé de formule (I): dans laquelle : R1 et R2, identiques ou différents, représentent chacun un atome d'hydrogène ou un groupement acyle ou alkyle, Ar représente un groupement aryle ou hétéroaryle, A représente un groupement choisi parmi: R4 représente un atome d'hydrogène ou un groupement alkyle, R5 représente un atome d'hydrogène ou un groupement choisi parmi alkyle, aryle et hétéroaryle, R3 représente un groupement aryle, hétéroaryle, dicyclopropylméthyle ou benzhydryle, ou A-R3 représente un groupement naphtyle éventuellement substitué, à l'exclusion de la 2,5-dihydroxy-3-(4-méthoxyphényl)-6-(2-phényléthényl)-1,4-benzoquinone, de la 2,5-dihydroxy-3-(4-méthoxyphényl)-6-(2-naphtyl)-1,4-benzoquinone, et de la 2,5-dihydroxy-3-(2-naphtyl)-6-phényl-1,4-benzoquinone. Médicaments.

公开(公告)号：AU2003226860B2

公开(公告)日：2008-06-26

申请号：AU2003226860

申请日：2003-02-04

Applicant: SERVIER LAB

Inventor： RENARD PIERRE ,  BAUT GUILLAUME LE ,  DUFLOS MURIEL ,  HUSSON-ROBERT BERNADETTE ,  DASSONVILLE ALEXANDRA ,  PFEIFFER BRUNO ,  LEVENS NIGEL ,  BRETECHE ANNE

IPC: C07C50/28 ,  A61K31/122 ,  A61K31/222 ,  A61K31/4402 ,  A61P3/10 ,  C07C45/00 ,  C07C45/28 ,  C07C46/00 ,  C07C46/10 ,  C07C50/30 ,  C07D213/50

Abstract: Compound of formula (I): wherein: R 1 and R 2 , which may be identical or different, each represents hydrogen, acyl or alkyl, Ar represents aryl or heteroaryl, A represents a group selected from: R 4 represents hydrogen or alkyl, R 5 represents hydrogen, alkyl, aryl or heteroaryl, R 3 represents aryl, heteroaryl, dicyclopropylmethyl or benzhydryl, or A-R 3 represents an optionally substituted naphthyl group, with the exclusion of 2,5-dihydroxy-3-(4-methoxyphenyl)-6-(2-phenylethenyl)-1,4-benzoquinone, 2,5-dihydroxy-3-(4-methoxyphenyl)-6-(2-naphthyl)-1,4-benzoquinone and 2,5-dihydroxy-3-(2-naphthyl)-6-phenyl-1,4-benzoquinone. Medicinal products containing the same which are useful in the treatment of diseases associated with a deregulation of glycaemia.

公开(公告)号：GEP20063900B

公开(公告)日：2006-08-10

申请号：GEAU2003008395

申请日：2003-02-04

Applicant: SERVIER LAB

Inventor： PFEIFFER BRUNO ,  RENARD PIERRE ,  DASSONVILLE ALEXANDRA ,  BRETECHE ANNE ,  DUFLOS MURIEL ,  LE BAUT GUILLAUME ,  LEVENS NIUGEL ,  HUSSON-ROBERT BERNADETTE

IPC: C07C50/28 ,  A61K31/122 ,  A61K31/222 ,  A61K31/4402 ,  A61P3/10 ,  C07C45/00 ,  C07C45/28 ,  C07C46/00 ,  C07C46/10 ,  C07C50/30 ,  C07D213/50

Abstract: A compound of formula (I), wherein R1, R2, R3, A and Ar are defined in the description.

公开(公告)号：NO20043532A

公开(公告)日：2004-08-24

申请号：NO20043532

申请日：2004-08-24

Applicant: SERVIER LAB

Inventor： RENARD PIERRE ,  LEVENS NIGEL ,  HUSSON-ROBERT BERNADETTE ,  DUFLOS MURIEL ,  PFEIFFER BRUNO ,  DASSONVILLE ALEXANDRA ,  BRETECHE ANNE ,  BAUT GUILLAUME LE

IPC: A61K31/122 ,  A61K31/222 ,  A61K31/4402 ,  A61P3/10 ,  C07C45/00 ,  C07C45/28 ,  C07C46/00 ,  C07C46/10 ,  C07C50/28 ,  C07C50/30 ,  C07D213/50

CPC classification number: C07D213/50 ,  C07C45/00 ,  C07C45/28 ,  C07C46/00 ,  C07C50/28 ,  C07C49/245

公开(公告)号：AU2003226860B8

公开(公告)日：2008-07-10

申请号：AU2003226860

申请日：2003-02-04

Applicant: SERVIER LAB

Inventor： RENARD PIERRE ,  BAUT GUILLAUME LE ,  DUFLOS MURIEL ,  HUSSON-ROBERT BERNADETTE ,  DASSONVILLE ALEXANDRA ,  PFEIFFER BRUNO ,  LEVENS NIGEL ,  BRETECHE ANNE

IPC: C07C50/28 ,  A61K31/122 ,  A61K31/222 ,  A61K31/4402 ,  A61P3/10 ,  C07C45/00 ,  C07C45/28 ,  C07C46/00 ,  C07C46/10 ,  C07C50/30 ,  C07D213/50

Abstract: Compound of formula (I): wherein: R 1 and R 2 , which may be identical or different, each represents hydrogen, acyl or alkyl, Ar represents aryl or heteroaryl, A represents a group selected from: R 4 represents hydrogen or alkyl, R 5 represents hydrogen, alkyl, aryl or heteroaryl, R 3 represents aryl, heteroaryl, dicyclopropylmethyl or benzhydryl, or A-R 3 represents an optionally substituted naphthyl group, with the exclusion of 2,5-dihydroxy-3-(4-methoxyphenyl)-6-(2-phenylethenyl)-1,4-benzoquinone, 2,5-dihydroxy-3-(4-methoxyphenyl)-6-(2-naphthyl)-1,4-benzoquinone and 2,5-dihydroxy-3-(2-naphthyl)-6-phenyl-1,4-benzoquinone. Medicinal products containing the same which are useful in the treatment of diseases associated with a deregulation of glycaemia.

公开(公告)号：EA006775B1

公开(公告)日：2006-04-28

申请号：EA200400992

申请日：2003-02-04

Applicant: SERVIER LAB

Inventor： DASSONVILLE ALEXANDRA ,  BRETECHE ANNE ,  DUFLOS MURIEL ,  LE BAUT GUILLAUME ,  PFEIFFER BRUNO ,  RENARD PIERRE ,  LEVENS NIGEL ,  HUSSON-ROBERT BERNADETTE

IPC: C07C50/28 ,  A61K31/122 ,  A61K31/222 ,  A61K31/4402 ,  A61P3/10 ,  C07C45/00 ,  C07C45/28 ,  C07C46/00 ,  C07C46/10 ,  C07C50/30 ,  C07D213/50

Abstract: Соединениеформулы (I)вкоторой Rи R, которыемогутбытьодинаковымиилиразличными, каждыйпредставляетсобойатомводорода, илиацильную, илиалкильнуюгруппу, Ar представляетсобойарильнуюгруппуилигетероарильнуюгруппу, Апредставляетсобойгруппу, выбраннуюизRпредставляетсобойатомводородаилиалкильнуюгруппу, Rпредставляетсобойатомводородаилигруппу, выбраннуюизалкильнойгруппы, арильнойгруппыи гетероарильнойгруппы, Rпредставляетсобойарильнуюгруппу, гетероарильнуюгруппу, дициклопропилметильнуюгруппуилибензгидрильнуюгруппу, или A-Rпредставляетсобойнеобязательнозамещённуюнафтильнуюгруппу, заисключением 2,5-дигидрокси-3-(4-метоксифенил)-6-(2-фенилэтенил)-1,4-бензохинона, 2,5-дигидрокси-3-(4-метоксифенил)-6-(2-нафтил)-1,4-бензохинонаи 2,5-дигидрокси-3-(2-нафтил)-6-фенил-1,4-бензохинона. Лекарственныесредства.

公开(公告)号：AR038397A1

公开(公告)日：2005-01-12

申请号：ARP030100368

申请日：2003-02-06

Applicant: SERVIER LAB

Inventor： DASSONVILLE ALEXANDRA ,  BRETECHE ANNE ,  DUFLOS MURIEL ,  LE BAUT GUILLAUME ,  PFEIFFER BRUNO ,  RENARD PIERRE ,  LEVENS NIGEL ,  HUSSON-ROBERT BERNADETTE

IPC: A61K31/122 ,  A61K31/222 ,  A61K31/4402 ,  A61P3/10 ,  C07C45/00 ,  C07C45/28 ,  C07C46/00 ,  C07C46/10 ,  C07C50/28 ,  C07C50/30 ,  C07D213/50

Abstract: Compuesto de fórmula (1) en la cual R1 y R2 idénticos o diferentes, representan cada uno un átomo de H o un grupo acilo o alquilo, Ar representa un grupo arilo o heteroarilo, A representa un grupo elegido entre:---C:::C---, estructura (2) , ---CR4=CR5--, R4 representa un átomo de H o un grupo alquilo, R5 representa un átomo de H o un grupo elegido entre alquilo, arilo, y heteroarilo,, R3 representa un grupo arilo, heteroarilo, diciclopropilmetilo o bencidrilo, o A-R3 representa un grupo naftilo eventualmente sustituido, a excepción de la 2,5-dihidro-3-(4-metoxifenil)-6-(2-feniletenil)-1,4-benzoquinona, la 2,5-dihidroxi-3-(4-metoxifenil)-o-(2-naftil)-1,4-benzoquinona, y la 2,5-dihidroxi-3-(2-naftil)-6-fenil-1,4-benzoquinona. Medicamentos.

公开(公告)号：AU2003226860A1

公开(公告)日：2003-09-02

申请号：AU2003226860

申请日：2003-02-04

Applicant: SERVIER LAB

Inventor： DASSONVILLE ALEXANDRA ,  BRETECHE ANNE ,  DUFLOS MURIEL ,  BAUT GUILLAUME LE ,  PFEIFFER BRUNO ,  RENARD PIERRE ,  LEVENS NIGEL ,  HUSSON-ROBERT BERNADETTE

IPC: A61K31/122 ,  A61K31/222 ,  A61K31/4402 ,  A61P3/10 ,  C07C45/00 ,  C07C45/28 ,  C07C46/00 ,  C07C46/10 ,  C07C50/28 ,  C07C50/30 ,  C07D213/50

Abstract: Compound of formula (I): wherein: R 1 and R 2 , which may be identical or different, each represents hydrogen, acyl or alkyl, Ar represents aryl or heteroaryl, A represents a group selected from: R 4 represents hydrogen or alkyl, R 5 represents hydrogen, alkyl, aryl or heteroaryl, R 3 represents aryl, heteroaryl, dicyclopropylmethyl or benzhydryl, or A-R 3 represents an optionally substituted naphthyl group, with the exclusion of 2,5-dihydroxy-3-(4-methoxyphenyl)-6-(2-phenylethenyl)-1,4-benzoquinone, 2,5-dihydroxy-3-(4-methoxyphenyl)-6-(2-naphthyl)-1,4-benzoquinone and 2,5-dihydroxy-3-(2-naphthyl)-6-phenyl-1,4-benzoquinone. Medicinal products containing the same which are useful in the treatment of diseases associated with a deregulation of glycaemia.

公开(公告)号：NZ534099A

公开(公告)日：2006-09-29

申请号：NZ53409903

申请日：2003-02-04

Applicant: SERVIER LAB

Inventor： DASSONVILLE ALEXANDRA ,  BRETECHE ANNE ,  DUFLOS MURIEL ,  LE BAUT GUILLAUME ,  PFEIFFER BRUNO ,  RENARD PIERRE ,  LEVENS NIGEL ,  HUSSON-ROBERT BERNADETTE

IPC: A61K31/122 ,  A61K31/222 ,  A61K31/4402 ,  A61P3/10 ,  C07C45/00 ,  C07C45/28 ,  C07C46/00 ,  C07C46/10 ,  C07C50/28 ,  C07C50/30 ,  C07D213/50

Abstract: Disclosed are compounds of formula (I), wherein: R1 and R2 are independently H, acyl or alkyl, Ar is aryl or heteroaryl, A is -CC-, cyclopropenyl, or -CR4=CR5-, R3 is aryl, heteroaryl, dicyclopropylmethyl or benzhydryl, or A-R3 is an optionally substituted naphthyl, wherein Ar is aryl. The compounds are used for the manufacture of medicaments for the treatment of diseases associated with a deregulation of glycaemia.